I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Canagliflozin: from glycemic control to improvement of card..:
M. V. Shestakova
;
A. S. Ametov
;
M. B. Antsiferov
...
https://www.dia-endojournals.ru/jour/article/view/12848. , 2022
Link:
https://doi.org/10.14341/DM12848
RT Journal T1
Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1de1479db44e46dc92bcabcb18bab681&Exemplar=1&LAN=DE A1 M. V. Shestakova A1 A. S. Ametov A1 M. B. Antsiferov A1 T. P. Bardymova A1 F. V. Valeeva A1 G. R. Galstyan A1 T. Yu. Demidova A1 I. A. Karpova A1 T. P. Kiseleva A1 A. Yu. Mayorov A1 A. M. Mkrtumyan A1 S. V. Nedogoda A1 N. А. Petunina A1 L. A. Ruyatkina A1 L. A. Suplotova A1 O. Yu. Sukhareva A1 V. V. Fadeev A1 M. S. Shamkhalova PB Endocrinology Research Centre YR 2022 K1 canagliflozin K1 sglt2i K1 sglt1 K1 type 2 diabetes mellitus K1 cardiovascular risks K1 renal risks K1 safety K1 Nutritional diseases. Deficiency diseases K1 RC620-627 JF https://www.dia-endojournals.ru/jour/article/view/12848 LK http://dx.doi.org/https://doi.org/10.14341/DM12848 DO https://doi.org/10.14341/DM12848 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)